Related Experiment Video
Updated: May 22, 2026
12:28
Establishing Cell Lines Overexpressing DR3 to Assess the Apoptotic Response to Anti-mitotic Therapeutics
Published on: January 11, 2019
Apoptosis-modulating drugs for improved cancer therapy
1Institute for Surgical Research, Philipps University Marburg, Marburg, Germany. ocker@staff.uni-marburg.de
Summary
Cancer cells resist cell death, but new therapies targeting apoptosis and other cell death pathways offer hope. These novel agents can overcome resistance, improve chemotherapy tolerability, and enhance survival rates in advanced cancers.
Area of Science:
- Oncology
- Molecular Biology
- Pharmacology
Background:
- Cancer's resistance to cell death induction is a key hallmark.
- Understanding molecular regulation of cell death (apoptosis, ER stress, autophagy, necroptosis) is advancing.
- Conventional chemotherapy often faces resistance, necessitating novel therapeutic strategies.
Purpose of the Study:
- To review cell death pathways involved in cancer.
- To summarize the development of specific cell death modulators.
- To explore how these modulators can improve chemotherapy and patient survival.
Main Methods:
- Review of scientific literature on cell death pathways.
- Analysis of novel therapeutic agents targeting cell death.
- Discussion of clinical implications for cancer treatment.
Main Results:
- Novel agents, including kinase inhibitors and antibodies, target survival pathways and death receptors.
- These agents demonstrate potential to overcome chemoresistance and apoptosis resistance.
- Targeted interference with cell death pathways offers improved treatment options.
Conclusions:
- Modulators of cell death represent a promising approach for cancer therapy.
- These therapies can enhance the efficacy of conventional chemotherapy.
- Improved tolerability and increased survival rates are anticipated for advanced cancer patients.
Related Concept Videos
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
01:31The Intrinsic Apoptotic Pathway
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
02:50Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
01:30Apoptosis
Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size reduction of the tissue.
01:15Drugs that Stabilize Microtubules
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...